Daily Immunoglobulin Replacement - a viable alternative?

• Research type

  Research Study

• Full title

  Is daily subcutaneous immunoglobulin acceptable to patients undergoing immunoglobulin replacement for immune deficiency?

• IRAS ID

  162230

• Contact name

  Lisa Vickers

• Contact email

  lisa.vickers@nhs.net

• Sponsor organisation

  NHS R&D

• Eudract number

  2014-004345-27

• Duration of Study in the UK

  0 years, 5 months, 0 days

• Research summary

  The aim of this study is to establish whether daily sub-cutaneous immunoglobulin replacement is an acceptable treatment option in terms of patient satisfaction and tolerability compared to weekly subcutaneous infusions, and to explore the factors influencing this choice. This will be achieved by in depth focus group discussions with patients changing from weekly subcutaneous infusions to smaller subcutaneous injections using a syringe and needle, multiple days per week.

• REC name

  South West - Cornwall & Plymouth Research Ethics Committee

• REC reference

  15/SW/0018

• Date of REC Opinion

  20 Feb 2015

• REC opinion

  Further Information Favourable Opinion